Annual Shareholders Equity
$28.93 M
-$84.75 M-74.55%
December 31, 2023
Summary
- As of February 7, 2025, IMUX annual stockholders equity is $28.93 million, with the most recent change of -$84.75 million (-74.55%) on December 31, 2023.
- During the last 3 years, IMUX annual shareholders equity has fallen by -$129.85 million (-81.78%).
- IMUX annual shareholders equity is now -81.78% below its all-time high of $158.78 million, reached on December 31, 2020.
Performance
IMUX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$41.22 M
-$22.35 M-35.16%
September 30, 2024
Summary
- As of February 7, 2025, IMUX quarterly stockholders equity is $41.22 million, with the most recent change of -$22.35 million (-35.16%) on September 30, 2024.
- Over the past year, IMUX quarterly shareholders equity has dropped by -$7.19 million (-14.85%).
- IMUX quarterly shareholders equity is now -74.69% below its all-time high of $162.88 million, reached on September 30, 2020.
Performance
IMUX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
IMUX Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -74.5% | -14.8% |
3 y3 years | -81.8% | -71.7% |
5 y5 years | +132.8% | -29.4% |
IMUX Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -77.2% | at low | -70.1% | +42.5% |
5 y | 5-year | -81.8% | at low | -74.7% | +42.5% |
alltime | all time | -81.8% | +152.7% | -74.7% | +171.1% |
Immunic Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $41.22 M(-35.2%) |
Jun 2024 | - | $63.57 M(-23.9%) |
Mar 2024 | - | $83.58 M(+188.9%) |
Dec 2023 | $28.93 M(-74.6%) | $28.93 M(-40.2%) |
Sep 2023 | - | $48.41 M(-30.1%) |
Jun 2023 | - | $69.28 M(-24.0%) |
Mar 2023 | - | $91.22 M(-19.8%) |
Dec 2022 | $113.68 M(-10.6%) | $113.68 M(+4.5%) |
Sep 2022 | - | $108.81 M(-14.9%) |
Jun 2022 | - | $127.85 M(-7.3%) |
Mar 2022 | - | $137.96 M(+8.5%) |
Dec 2021 | $127.11 M(-19.9%) | $127.11 M(-12.6%) |
Sep 2021 | - | $145.47 M(+20.5%) |
Jun 2021 | - | $120.74 M(-12.2%) |
Mar 2021 | - | $137.45 M(-13.4%) |
Dec 2020 | $158.78 M(+172.1%) | $158.78 M(-2.5%) |
Sep 2020 | - | $162.88 M(+107.0%) |
Jun 2020 | - | $78.69 M(+55.8%) |
Mar 2020 | - | $50.49 M(-13.5%) |
Dec 2019 | $58.36 M(+369.6%) | $58.36 M(-3.6%) |
Sep 2019 | - | $60.53 M(-12.8%) |
Jun 2019 | - | $69.41 M(+667.1%) |
Mar 2019 | - | $9.05 M(-27.2%) |
Dec 2018 | $12.43 M | $12.43 M(-12.8%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2018 | - | $14.25 M(-46.1%) |
Jun 2018 | - | $26.45 M(-29.1%) |
Mar 2018 | - | $37.30 M(-25.5%) |
Dec 2017 | $50.04 M(-14.4%) | $50.04 M(-19.4%) |
Sep 2017 | - | $62.08 M(-15.4%) |
Jun 2017 | - | $73.34 M(-13.1%) |
Mar 2017 | - | $84.43 M(+44.5%) |
Dec 2016 | $58.45 M(-29.0%) | $58.45 M(-13.7%) |
Sep 2016 | - | $67.76 M(-8.6%) |
Jun 2016 | - | $74.15 M(-5.0%) |
Mar 2016 | - | $78.05 M(-5.2%) |
Dec 2015 | $82.33 M(-15.6%) | $82.33 M(+40.3%) |
Sep 2015 | - | $58.68 M(-15.9%) |
Jun 2015 | - | $69.74 M(-16.8%) |
Mar 2015 | - | $83.78 M(-14.1%) |
Dec 2014 | $97.56 M(-318.5%) | $97.56 M(+26.6%) |
Sep 2014 | - | $77.05 M(-13.6%) |
Jun 2014 | - | $89.16 M(-253.7%) |
Mar 2014 | - | -$58.02 M(+29.9%) |
Dec 2013 | -$44.66 M(+485.1%) | -$44.66 M(+35.8%) |
Sep 2013 | - | -$32.88 M(+36.1%) |
Jun 2013 | - | -$24.17 M(+216.7%) |
Dec 2012 | -$7.63 M(-86.1%) | -$7.63 M |
Dec 2011 | -$54.85 M | - |
FAQ
- What is Immunic annual stockholders equity?
- What is the all time high annual shareholders equity for Immunic?
- What is Immunic annual shareholders equity year-on-year change?
- What is Immunic quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Immunic?
- What is Immunic quarterly shareholders equity year-on-year change?
What is Immunic annual stockholders equity?
The current annual shareholders equity of IMUX is $28.93 M
What is the all time high annual shareholders equity for Immunic?
Immunic all-time high annual stockholders equity is $158.78 M
What is Immunic annual shareholders equity year-on-year change?
Over the past year, IMUX annual stockholders equity has changed by -$84.75 M (-74.55%)
What is Immunic quarterly stockholders equity?
The current quarterly shareholders equity of IMUX is $41.22 M
What is the all time high quarterly shareholders equity for Immunic?
Immunic all-time high quarterly stockholders equity is $162.88 M
What is Immunic quarterly shareholders equity year-on-year change?
Over the past year, IMUX quarterly stockholders equity has changed by -$7.19 M (-14.85%)